Clinical Evidence of pH Dependent ß2 Adrenergic Transport Mechanisms in the Airway
2 other identifiers
interventional
10
1 country
1
Brief Summary
The purpose of this study was to determine if airway pH has an effect on albuterol-induced vasodilation in the airway. Methods: Ten healthy volunteers performed the following respiratory maneuvers: quiet breathing, hypocapnic hyperventilation, hypercapnic hyperventilation, and eucapnic hyperventilation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy-volunteers
Started Jan 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 6, 2010
CompletedFirst Posted
Study publicly available on registry
October 7, 2010
CompletedResults Posted
Study results publicly available
December 17, 2014
CompletedMay 27, 2016
November 1, 2014
6 months
October 6, 2010
September 2, 2014
April 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Airway Blood Flow After 180μg Albuterol by Inhalation (ΔQaw) vs Baseline
Effect of airway pH on albuterol responsiveness as reflected by the change in airway blood flow after 180μg albuterol by inhalation (ΔQaw) vs baseline.
15 minutes after albuterol inhalation
Secondary Outcomes (1)
Exhaled Breath Condensate (EBC) pH Variation
10 minutes after each respiratory manouver.
Study Arms (1)
health life-time non smokers
EXPERIMENTALhealth lifetime non-smokers will be challenged with 4 respiratory maneuvers:quiet breathing, hypocapnic hyperventilation, hypercapnic hyperventilation, and eucapnic hyperventilation
Interventions
Subjects were instructed to breath normally at room air.
hypocapnic hyperventilation, the subjects were instructed to breathe fast and deep until their end-tidal pCO2 fell to 30 mmHg, corresponding to a systemic pH increase of about 0.1 pH units.
For hypercapnic hyperventilation, a modification of a previously described procedure (15). While monitoring SaO2 using pulse oximetry and end-tidal CO2 by mass-spectrometry on a breath by breath basis, CO2 was bled into the inspired air to achieve an end-tidal pCO2 of at least 55 mmHg
For eucapnic hyperventilation, the subjects were instructed to increase their ventilation to the highest level of ventilation recorded in the previous two hyperventilation maneuvers, while CO2 was bled into the inspired air to maintain end-tidal pCO2 at 40 mmHg.
Eligibility Criteria
You may qualify if:
- Lifetime non-smokers
- FEV1 \> 80% predicted value and FEV1/FVC \> 0.75
You may not qualify if:
- Cardiovascular disease or use of cardiovascular or vasoactive drugs;
- Lung disease or use of airway drugs (i.e. inhaled corticosteroids, β adrenergic agonists);
- Respiratory infection during the 4 weeks preceding the study
- Use of systemic glucocorticoids within 4 weeks of the study
- Pregnant or nursing females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- National Institutes of Health (NIH)collaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Pulmonary Human Research Laboratory, University of Miami School of Medicine
Miami, Florida, 33136, United States
Related Publications (4)
Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Hom S, Gaston B, Hunt J. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J. 2003 Dec;22(6):889-94. doi: 10.1183/09031936.03.00038803.
PMID: 14680074BACKGROUNDPaget-Brown AO, Ngamtrakulpanit L, Smith A, Bunyan D, Hom S, Nguyen A, Hunt JF. Normative data for pH of exhaled breath condensate. Chest. 2006 Feb;129(2):426-430. doi: 10.1378/chest.129.2.426.
PMID: 16478862BACKGROUNDHorvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, Wanner A. Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol. 2007 Jan;36(1):53-60. doi: 10.1165/rcmb.2006-0230OC. Epub 2006 Aug 17.
PMID: 16917073BACKGROUNDCancado JE, Mendes ES, Arana J, Horvath G, Monzon ME, Salathe M, Wanner A. Effect of airway acidosis and alkalosis on airway vascular smooth muscle responsiveness to albuterol. BMC Pharmacol Toxicol. 2015 Apr 2;16:9. doi: 10.1186/s40360-015-0008-y.
PMID: 25889594DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Matthias Salathe, MD
- Organization
- University of Miami
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Salathe
University of Miami
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
October 6, 2010
First Posted
October 7, 2010
Study Start
January 1, 2010
Primary Completion
July 1, 2010
Study Completion
August 1, 2010
Last Updated
May 27, 2016
Results First Posted
December 17, 2014
Record last verified: 2014-11